TickerFacts.

Oragenics Inc (OGEN): Total Liabilities

Annual figures by period end, from SEC filings.

$1.79M
As of 2025-12-31
$1.82M
As of 2026-06-30
$9.45M2010-12-31: $3.63M2011-12-31: $9.45M2023-12-31: $1.80M2024-12-31: $1.68M2025-12-31: $1.79M$1.79M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.79M+6.1%2026-03-16, Balance as of period end
2024-12-31$1.68M-6.3%2026-03-16, Balance as of period end
2023-12-31$1.80Mn/a2025-03-14, Balance as of period end
No annual figure between 2011-12-31 and 2023-12-31.
2011-12-31$9.45M+160.4%2012-04-16, Balance as of period end
2010-12-31$3.63Mn/a2012-04-16, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Oragenics Inc (OGEN)2025-12-31$1.79M+6.1%
Medicus Pharma Ltd. (MDCX)2025-12-31$10.02M+299.0%
Genprex, Inc. (GNPX)2025-12-31$2.20M-12.3%
Longeveron Inc. (LGVN)2025-12-31$4.59M+24.9%
Cocrystal Pharma, Inc. (COCP)2025-12-31$3.38M-14.0%
MAIA Biotechnology, Inc. (MAIA)2025-12-31$7.33M+12.4%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)2025-12-31$8.22M+357.5%
FibroBiologics, Inc. (FBLG)2025-12-31$3.46M-74.7%
Traws Pharma, Inc. (TRAW)2025-12-31$11.25M-80.1%

Compare OGEN, MDCX, GNPX, LGVN side by side · Screen every company in Pharmaceutical Preparations ↗